Drug Trial Radar · NCT02215265
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Last checked: Nov 20, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,269
Planned (sponsor's estimate)
Start
Oct 2015
Primary completion
Oct 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Lisette NixonGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- UNICANCER; AdventHealth; University of Leipzig; Princess Alexandra Hospital, Brisbane, Australia; Stanford University
- First posted
- Aug 13, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objectives of the PATHOS study are: To assess whether swallowing function can be improved following transoral resection of HPV-positive OPSCC, by reducing the intensity of adjuvant treatment protocols. The aim is to personalise treatment, based on disease biology (HPV status and pathology findings), to optimise patient outcomes. To demonstrate the non-inferiority of reducing the intensity of adjuvant treatment protocols in terms of overall survival in the reduced intensity treatment arms.
Conditions
- Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Interventions
CisplatinDrug
Chemotherapy
Postoperative radiotherapyRadiation
Postoperative radiotherapy (PORT)
Primary outcomes
What the sponsor says the trial is designed to measure.
- MDADI/Overall survival co-primary endpointTime frame: At 12 months following treatment measured using the MD Anderson Dysphagia Inventory (MDADI) score.
Locations
57 sites in 5 countries. Site status is shown where the registry gives one.
Board of Trustees of the Leland Stanford Junior University
Redwood City, California
Advent Health
Orlando, Florida
MD Anderson Cancer Centre
Houston, Texas
Metro South Health
Brisbane, Australia
Unicancer
Paris, France
Vivantes Klinikum
Berlin, Germany
Zentrum für Hals-, Nasen- und Ohrenheilkunde
Giessen, Germany
Asklepios Kliniken
Hamburg, Germany
Kath Marienkrankenhaus gGmbH
Hamburg, Germany
Universitaetsklinikum des Saarlandes
Homburg, Germany
Universitat Leipzig
Leipzig, Germany
Ernst von Bergmann Klinikum
Potsdam, Germany
Städtisches Klinikum Solingen
Solingen, Germany
Universitätsklinikum Ulm
Ulm, Germany
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom
Queen Elizabeth Hospital
Birmingham, United Kingdom
Royal Blackburn Hospital
Blackburn, United Kingdom
Royal Sussex County Hospital
Brighton, United Kingdom
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Kent and Canterbury Hospital
Canterbury, United Kingdom
HPV Research Group Section of Pathology Cardiff University ,School of Medicine
Cardiff, United Kingdom
Cardiff and Vale University Local Health Board
Cardiff, United Kingdom
Centre for Trials Research
Cardiff, United Kingdom
Velindre NHS Trust
Cardiff, United Kingdom
Castle Hill Hospital
Cottingham, United Kingdom
Derby Teaching Hospitals NHS Foundation Trust
Derby, United Kingdom
Western General Hospital
Edinburgh, United Kingdom
Royal Devon University Health Care NHS Foundation Trust
Exeter, United Kingdom
Royal Surrey County Hospital
Guildford, United Kingdom
St James University Hospital
Leeds, United Kingdom
Liverpool Head and Neck Centre
Liverpool, United Kingdom
University of Liverpool
Liverpool, United Kingdom
Cwm Taf Bro Morganwg
Llantrisant, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Guys and St Thomas's NHS Foundation Trust
London, United Kingdom
St Georges University Hospital
London, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
Central Manchester University Hospital NHS Foundation Trust
Manchester, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.